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Abstract
Objective: Few studies have prospectively evaluated the utility of geriatric assessment tools as predictors of
mortality in the oldest population. We investigated predictors of death in an oldest-old cohort after 3 years of
follow-up.
Methods: The Octabaix study is a prospective, community-based study with a follow-up period of 3 years
involving 328 subjects aged 85 at baseline. Data were collected on functional and cognitive status, co-morbidity,
nutritional and falls risk, quality of life, social risk, and long-term drug prescription. Vital status for the total
cohort was evaluated after 3 years of follow-up.
Results: Mortality after 3 years was 17.3%. Patients who did not survive had significantly poorer baseline
functional status for basic and instrumental activities of daily living (Barthel and Lawton Index), higher co-
morbidity (Charlson), higher nutritional risk (Mini Nutritional Assessment), higher risk of falls (Tinetti Gait
Scale), poor quality of life (visual analog scale of the Quality of Life Test), and higher number of chronic drugs
prescribed. Cox regression analysis identified the Lawton Index (hazard ratio [HR] 0.82, 95% confidence interval
[CI] 0.73–0.89) and the number of chronic drugs prescribed (HR 1.09, 95% CI 1.01–1.18) as independent pre-
dictors of mortality at 3 years.
Conclusions: Among the variables studied, the ability to perform instrumental activities of daily living and using
few drugs on a chronic basis at baseline are the best predictors of which oldest-old community-dwelling subjects
survive after a 3-year follow-up period.
Introduction
Life expectancy is increasing rapidly throughout thedeveloped world, leading to more people surviving to
very old ages. In almost all developed countries, the average
life span of men and women continues to increase. Conse-
quently, the oldest old is a growing population segment.1
Nevertheless, few studies have prospectively evaluated
predictors of mortality exclusively in older adults,2,3 and
even less information exists on the group of oldest old.4–6
This subject has been addressed in a comprehensive
manner with long-term follow-up registries such as the Lei-
den 85-plus study,6 which found blood pressure7 or eryth-
ropoietin8 levels to predict long-term mortality in the cohort.
Recently, Taekema et al.6 reported that gait speed in the
oldest old is a useful tool to assess survival prognosis in this
population.
Chronic conditions are a strong predictor of mortality among
younger elderly subjects. In addition, functional limitation has
been found to strongly predict mortality among the oldest old.9
Our group evaluated a cohort of nonagenarians living in our
area (the Nonasantfeliu study) and found that general geriatric
assessment tools were valuable in the prediction of short- and
long-term mortality.10,11
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In the present study, we prospectively followed a broad
sample of subjects aged 85 years old in our geographical area
and assessed mortality within a 3-year period. Due to the
importance of general geriatric assessment of the oldest-old
subjects, the main objective was to examine whether any of
the tools that are regularly used in community geriatric as-
sessment would be useful to detect the group of patients
among this cohort with a high risk of mortality within these
3 years of follow-up.
Methods
The Octabaix study is a prospective cohort study incor-
porating a double-blind, parallel-group, randomized clinical
trial on falls and nutritional risk. A total of 328 community-
dwelling persons born in 1924 (85 years old at the time of
inclusion) who were registered with one of seven primary
care teams in the geographical area of Baix Llobregat, Bar-
celona, Spain, were included; this sample is described in
more detail elsewhere.12,13 In brief, every old inhabitant was
interviewed at their home or their health center by a research
team with a training in geriatrics. The institutional ethics
committee of the local health system approved the design of
the study, and all patients, or the caregivers of cognitively
impaired subjects, gave their written informed consent be-
fore enrollment. No criteria related to baseline health or
cognitive status were applied to exclude patients. Socio-
demographic data (gender, marital status, place of residence,
studies, and living alone) and a comprehensive geriatric
evaluation (functional, cognitive and nutritional status, social
risk, gait, and risk of falls) based on tools currently used in
geriatric practice were included in this evaluation.
Functional status was measured using the Barthel Index
(BI)14 for basic activities of daily living (ADL) and the
Lawton Index15 (LI) for instrumental ADL. The LI is an easy-
to-administer assessment instrument that provides self-
reported information about functional skills necessary to live
in the community. LI scores range from 0 (low function,
dependent) to 8 (high function, independent). Historically,
women were scored on all eight areas of function; men were
not scored in the domains of food preparation, housekeep-
ing, and laundering. However, we applied the current rec-
ommendations to assess all domains for both genders.16 A
limitation of the instrument includes the self-report or sur-
rogate report method of administration rather than a dem-
onstration of the functional task. BI measures include
questions about seven areas: Feeding, bathing, personal hy-
giene, dressing, bowel/bladder control, getting on/off the
toilet, and locomotion. A maximum score of 100 indicates
that the subject is independent in physical function and the
lowest score of 0 indicates a totally dependent state. Cogni-
tive function was measured by the Spanish version of the
Mini-Mental State Examination (MEC), which has a total
score of 35; as recommended, we considered scores below or
equal to 23 to indicate the presence of cognitive impair-
ment.17 Nutritional status was assessed using the Mini Nu-
tritional Assessment (MNA).18 The MNA score is based on
18 items covering four component sub-scores. The MNA
score incorporates 18 items sub-divided in four components:
MNA-1 (four items), anthropometric measurement (0–8
points); MNA-2 (six items), overall evaluation (0–9 points);
MNA-3 (six items), assessment of dietary habits (0–9 points);
and MNA-4 (two items), subjective assessment of self-
perceived quality of health and nutrition (0–4 points). The
score obtained (maximum 30 points) classifies the sub-
jects assessed into three categories: 24–30, well-nourished;
17–23.5, at risk of malnutrition; and < 17, malnourished. Gait
was evaluated with the Gait Rating Scale from the Tinetti
Performance-Oriented Mobility Assessment. The gait com-
ponent of this scale evaluates seven items: Initiation of gait,
step height and length, step symmetry and continuity, path
deviation, trunk stability, walking stance, and turning while
walking. The scale provides a final score that ranges from 0
to 12, with a higher score indicating better gait perfor-
mance.19 A fall was defined as any incident in which the
patient ends up on the ground or at a lower level against
his/her will (and not due to an intentional movement).20
Patients and/or caregivers were asked about the number of
falls in the last year. The Gijon scale was used for the social
assessment.21 This scale is scored on a maximum of 24
points. Social risk scores are those between 10 and 14 and
social problems exist with scores > 15. Quality of life was
assessed using the visual analog scale of the Quality of Life
Test (EQ-VAS) of perceived health.22 The EQ VAS records
the respondent’s self-rated health on a 20-cm vertical, visual
analog scale with end points labeled ‘‘the best health you can
imagine’’ (100) and ‘‘the worst health you can imagine’’ (0).
The Charlson score (CS) was used to measure overall co-
morbidity.23 It ranges from 0 to a theoretical maximum of 33,
depending on the presence of certain diseases with assigned
values. Age-adjusted CS was not used because all partici-
pants were 85 year olds. Cardiovascular risk factors such as
treatment for high blood pressure (HBP) above 140/90
(clinical measurement of blood pressure is calculated using
the average of two morning measures in upright position),
diabetes mellitus (DM), and dyslipidemia were also re-
corded. Disease prevalence for stroke and dementia was
determined on the basis of data review from general practice
records. The number of drugs used by prescription on a
chronic basis was also recorded. In most cases, the physician
who obtained the information was at the same time the one
who usually cared for the patient; co-morbidity data were
therefore not only derived from self-report but also from
chart reviews, test results, and prescription drug indications.
Intervention
During the first and second year, an intervention to reduce
the risk of falls and malnutrition was implemented in a ran-
domized fashion. The intervention was administered to 164
subjects (136 completed the 2-year program) and consisted of a
community-based multifactorial program that links partici-
pants to existing medical care and service networks. The con-
trol participants (164) received their usual health care. The
baseline characteristics of the two groups were similar in terms
of age, sex, living alone, co-morbidity, and most health-related
variables, including functional and cognitive status.13
Outcome events
Mortality, mesured as time-to-event data, is the main
outcome of this study. For that purpose, the vital status of
the participants was intermittently evaluated during the 3
years of follow-up; participants were categorized as alive
after 36 months of follow-up, or censored when they died,
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whichever occurred first. We chose a 3-year follow-up period
because it represents about 50% of the years of life expec-
tancy in the 85 year olds in our area (6.5 years).24
Mortality status and causes were determined by trained
physician adjudicators on the basis of medical records from
hospitalizations, emergency room visits, death certificates, and
autopsy and coroner’s reports, when available. We compared
the patients who had survived with those deceased.
Data analysis
Normally distributed continuous variables are reported as
mean– standard deviation (SD). Categorical variables are re-
ported as proportions. Normal or non-normal distributions of
continuous variables were assessed using the Kolmogorov–
Smirnov test. The Student t-test was used to compare contin-
uous variables, with a previous Levene test for equality of
variances, while either the chi-squared statistic or Fisher exact
test was used to compare categorical or dichotomous variables.
Cox models were adjusted between main outcome variable and
predictors. The semi-parametric Cox proportional hazards
model analyzes the relationship between a time-to-event re-
sponse variable and adjusted baseline covariates. Proportional
hazards and linearity (on continuous variables) assumptions
were evaluated for the Cox models to determine the variables
associated with 3-year mortality.
The variables entered into the model using a backward
stepwise approach were gender and all the variables with
significant differences in the bivariate analysis, such as the BI
and LI, Charlson Comorbidity Index, MNA, Tinetti Gait
Scale, EQ-VAS, and chronic drugs prescription. The signifi-
cance level was fixed at 5%. Because this is mainly an ex-
ploratory analysis and covariates associated with the main
outcome variable are unknown or not fully understood, we
performed an algorithm variable selection based solely on a
backward-stepwise approach. The variable selection process
was supervised by clinical criterion to ensure the result’s
reliability and meaningfulness. We repeated the model with
BI as categorical scores (BI > 90) and the results did not
change. Finally, we analyzed a third model that excluded
polypharmacy to evaluate the co-morbidity contributions
with the Charlson Index alone. The analyses were repeated
to explore associations by 1- and 2-year survival. An ad-
justed hazard ratio (HR) with a 95% confidence interval (CI)
was used. The results were considered significant when
p< 0.05. All analyses were performed using SPSS 15.0 sta-
tistical software (SPSS Inc., Chicago, IL).
Results
The characteristics of the 328 participants are summarized
in Table 1. In brief, the sample included 202 women (61.6%)
Table 1. Comparison of Variables Associated with 3-Year Survival:
Proportions and Mean (Standard Deviation) Are Shown
All (n = 328) Survivors (n = 271) Non-survivors (n = 57) p
Gender 0.67
Female 202 (61.6%) 173 (63.8%) 29 (50.9%)
Male 126 (38.4%) 98 (36.2%) 28 (49.1%)
Marital status 0.45
Widowed 174 (53%) 140 (51.7%) 34 (59.6%)
Married 134 (40.9%) 113 (41.7%) 21 (36.8%)
Unmarried 20 (6.1%) 18 (6.6%) 2 (3.5%)
Studies 0.44
No studies 113 (34.5%) 89 (32.8%) 24 (42.1%)
Primary studies 153 (46.6%) 129 (47.6%) 24 (42.1%)
High school 47 (14.3%) 39 (14.4%) 8 (14%)
University degree 15 (4.6%) 14 (5.2%) 1 (1.8%)
Living alone 100 (30.5%) 87 (32.1%) 13 (22.8%) 0.16
Barthel Index 87.6 – 19 88.8 – 18 81.8 – 25 0.01
Barthel Index > 90 131 (39.9%) 98 (36.2%) 33 (57.9%) 0.02
MEC 26.7 – 6.8 26.9 – 6.6 25.4 – 7.4 0.12
MEC < 24 90 (27.4%) 71 (26.2%) 19 (33.3%) 0.27
Lawton IADL Index 5.3 – 2.5 5.6 – 2.7 4.2 – 2.2 0.0001
Gijon 9.8 – 2.6 9.7 – 2.8 9.9 – 2.6 0.57
EQ-VAS 62 – 21 63.3 – 21.3 56.2 – 19.5 0.02
Charlson Index 1.4 – 1.6 1.3 – 1.4 2.0 – 2.1 0.001
MNA-SF 24.5 – 3.7 24.8 – 3.6 23.0 – 3,7 0.001
Tinetti 6.6 – 2.9 6.8 – 2.8 5.7 – 2.8 0.01
Hypertension 249 (75.9%) 208 (76.8%) 41 (71.9%) 0.43
Diabetes mellitus 58 (17.7%) 48 (17.7%) 10 (17.5%) 0.97
Dyslipidemia 168 (51.2%) 140 (51.7%) 28 (49.1%) 0.72
Medical history of stroke 49 (14.9%) 42 (15.5%) 7 (12.3% 0.53
Dementia 31 (9.5%) 25 (9.2%) 6 (10.5%) 0.76
Number of drugs taken 6 – 3 5.8 – 3.2 7.4 – 3.2 0.001
Falls 0.4 – 0.9 0.4 – 0.9 0.4 – 0.7 0.97
MEC, Spanish version of the Mini-Mental State Examination; IADL, Instrumental Activities of Daily Living; EQ-VAS, Quality of life with
the visual analog scale; MNA-SF, Mini Nutritional Assessment questionnaire (short form).
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and 126 men. Geriatric assessment tools at baseline showed
the following mean values: BI 87.6 – 19 for basic ADL,
Lawton 5.3 – 2.5 for instrumental ADL, MEC 26.7 – 6.8, MNA
24.5 – 3.7 for malnutrition risk, Tinetti Gait Scale 6.6 – 2.9 for
risk of falls, and Gijon test 9.8 – 2.6 for social risk. The mean
quality of life score assessed using the EQ-VAS was 62– 21.
The mean Charlson Index value was 1.4 – 1.6. Among major
cardiovascular risk factors, hypertension was found in 249
(75.9%) subjects, diabetes in 58 (17.8%), and dyslipidemia in
168 (51.2%). Forty-nine subjects had a previous history of
stroke (14.9%) and 31 of dementia (9.5%). Patients were
taking an average of 6.1 – 3 chronic drugs, with 253 patients
(77.1%) taking three or more. Ninety-four (28.6%) subjects
had suffered at least one fall during the previous year, and 25
(7.6%) had fallen two or more times. A total of 137 falls were
recorded during follow-up, a mean of 0.4 – 0.9 falls per
subject.
Evaluation after 3-year follow-up
Fifty-seven subjects died during the 36 months of the
follow-up period (17.3%). Hence, the annual average mor-
tality rate was 5.7%, and was distributed as follows: 4.9%
within the first year, 5.8% within the second, and 6.7%
within the third. Deaths were in absolute figures; the distri-
bution between females (29, 14.3% of women) and males (28,
22.2%) was not even.
Predictors of mortality
Thirty-six (22.2%) of the control subjects died during the
follow-up period, versus 21 (12.8%) ( p= 0.03) of the inter-
vention group participants. The bivariate analysis of baseline
variables associated with 3-year survival is shown in Table 1.
Patients who did not survive had significantly poorer base-
line functional status for both basic and instrumental activ-
ities of daily living, higher co-morbidity, higher nutritional
risk, higher risk of falls, worse quality of life, and were taking
more chronic prescription drugs.
Cox regression analysis identified two significant clinical
variables (LI values and number of chronic drugs used) among
those significant at the bivariate level as independent predictors
of 3-year risk of mortality for this cohort of octogenarians
(Table 2). When we applied the Cox model to evaluate mor-
tality after the first and second year of follow-up, lower LI
Index scores were the only significant predictors of higher
mortally, with a HR of 0.72, 95% CI 0.60–0.87 (p<0.001) and
0.81, 95% CI 0.71–0.91 (p<0.001), respectively.
When we excluded the polypharmacy of the model, the
Cox regression analysis identified the LI (HR 0.83, 95% CI
0.75–0.91) and the Charlson Index values (HR 1.17, 95% CI
1.01–1.36) as independent predictors of mortality after 3
years. However, only the LI remained significant when the
follow-up was restricted to 1 or 2 years.
Discussion
In our cohort of octogenarians, the mortality rate after 36
months of follow-up was 17.3% (4.9% after 12 months and
10.7% after 24 months). This 2-year mortality rate is very
similar to that reported for Jerusalem residents5 (9.8%), but
lower than that of the Leiden Study participants6 (16%).
Besides crude mortality rates, our main finding was that
the only predictors of mortality, among the variables stud-
ied, for a cohort of community-dwelling octogenarians at 3-
year follow-up were the inability to perform instrumental
activities of daily living and the use of higher numbers of
prescription drugs on a long-term basis.
Over the past two decades, there has been growing rec-
ognition of functional status assessment as a key factor in the
evaluation of older persons to help predict future mortality.25
Similar to our results, the Leiden 85 + study has reported
that instrumental activities of daily living dependence (as-
sessed using the Groningen Activity Restriction Scale) was
associated with an increased risk of mortality after 2 years.
This association persisted as far as 12 years after the baseline
evaluation.6 Spector et al.26 suggested that disability in in-
strumental ADL was a more sensitive predictor of functional
decline than disability in basic ADL alone. That is in con-
cordance with the results of our study and probably relates
to the very high proportion of individuals with normal or
almost normal baseline BI values. It is also important to note
that the LI was the only predictor of survival at 1- and 2-year
follow-up.
Regarding the second factor associated with mortality, it
remains unclear whether polypharmacy is a marker for poor
health or an independent risk factor, and conflicting results
have been reported on this association.27 This is perhaps
related to the different definitions of polypharmacy used; we
chose to analyze it as a continuous variable defined by the
total number of drugs taken. Recently, Richardson et al.28
have reported a variation over time in this association; a
strong independent association between polypharmacy and
mortality can be found in the short term (first 2 years) for
both men and women. The association remained, although to
a lesser degree, in the mid to long term (2–18 years of follow-
up) in women, but became non-significant in men. In con-
trast, our study showed this association to be present in the
mid-term (3 years), but not within the 2 first years of follow-
up. This association persisted when the diseases behind the
prescription were included in the multivariate analysis via
the Charlson Comorbidity Index, which itself does not show
statistical predictive value for mortality in this study. How-
ever, when we exclude polypharmacy from the regression
analyses, the Charlson Index was indeed predictive of mor-
tality in the mid-term.
Three other variables predicted mortality in the univariate
analysis but lost significance in the multi-variable model—
high nutritional risk, high risk of falls, and poor reported
quality of life. All of them have been found to predict mor-
bimortality in the elderly. MNA is the most frequently used
screening test for malnutrition in elderly populations and can
Table 2. Adjusted Cox Regression Analysis Model
of Baseline Variables for the Death of









IADL, Instrumental Activities of Daily Living.
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predict mortality in a general, community-dwelling elderly
population.29 Falls are the leading cause of injury-related
visits to emergency departments and the primary etiology of
accidental deaths in persons over the age of 65 years, and the
mortality rate for falls increases dramatically with age.30 Fi-
nally, quality of life evaluations, which take into account the
patient’s perceived health status, have also been shown to
predict mortality in elderly people.31
This study has several strengths, including its prospective
design, comprehensive set of measurements, and complete-
ness of follow-up. An important strength of the Octabaix
study is the use of a community-based sample of patients of
the same age. This sample is representative of the socio-
economic characteristics of the older residents in our area,
with a full range of co-morbidities. All subjects were regis-
tered with a general practitioner and benefitted from a full
range of public health facilities. However, the same-age re-
striction might limit the value of the findings of our study
when applied to an elderly population with a broader age
range. Also, this is a small sample size study and its findings
cannot probably be generalized to larger populations. A
factor to take into account is the potential gender bias of the
LI as we mentioned in the Methods section. Other limitations
should be acknowledged. Geriatric measurements were ta-
ken only at baseline, so it remains unknown whether age
declines in these test results might better predict mortality.
Another important limitation is the lack of biological data
and the clinical characteristics of the chronic diseases present
among the population included in the study. Moreover, the
prevalence of diseases or syndromes without straightfor-
ward diagnostic criteria, such as dementia, may be under-
estimated. Also, the backward data analysis method for the
models variable selection is not based in clinical criterion, it
is a hypothesis generation one, so results must be confirmed
in new specific studies. Finally, the analysis did not take into
account the possible beneficial effect of the study interven-
tion or the patients’ follow-up on the occurrence of adverse
events such as hospital admission episodes. However, it
must be noted that no differences in basal LI values between
individuals in the control group and the intervention sub-
groups (data not shown) exist.
In conclusion, our study shows that an objective evalua-
tion based on comprehensive geriatric assessment tools
might be useful to predict mortality risk when performed on
oldest-old, community-dwelling subjects. In particular, the
ability to perform instrumental activities of daily living and
taking fewer prescription drugs (two characteristics amena-
ble to at least partial intervention) seem to predict a better
chance of survival in this population.
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